2029, Leads and Side effects - Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2029

Leads

Side effects

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

JUNE 16, 2023

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines. As the data landscape evolves, what is the most exciting innovation in clinical data management.

Safety

Safety Electronics Recruitment Patients

Managing the next pandemic: the role of nasal vaccine administration

European Pharmaceutical Review

AUGUST 30, 2022

Nasal delivery is non-invasive and provides a more targeted delivery than the systemic injectable approach, potentially offering a quicker response and reduced side effects. million by 2029, up from $122.287 million in 2021. Key to overcoming many of these challenges lies in the evolution of nasal spray device design.

Management

Management Manufacturing Marketing Side effects

Digitalisation of the clinical trial landscape

Managing the next pandemic: the role of nasal vaccine administration

Stay Connected